FT
Flow Traders U.S. LLC
13F filer · CIK 0001466697Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$2.43BU.S. long equity reported on 13F
Positions337174 new · 120 closed
Net flow last quarter-$21.8MBuys minus sells
Top 10 positions weight9.9%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 2026337 positions | |||||
| $86.7M | 3.56% | 0.03% | New | Q2 2026 | |
| $41.8M | 1.72% | Not reported | Not reported | Q2 2016 | |
| $32.3M | 1.33% | Not reported | Not reported | Q3 2013 | |
| $20.3M | 0.84% | 0.28% | Not reported | Q3 2024 | |
| $10.5M | 0.43% | Not reported | -73.6% | Q2 2025 | |
| $10.4M | 0.43% | 0.00% | -15.1% | Q3 2018 | |
| $10.3M | 0.42% | 0.00% | Not reported | Q3 2022 | |
| $9.68M | 0.40% | 0.02% | Not reported | Q2 2013 | |
| $9.45M | 0.39% | 0.00% | +1281.0% | Q1 2017 | |
| $9.26M | 0.38% | 0.09% | Not reported | Q1 2024 | |
| $8.21M | 0.34% | Not reported | +125.8% | Q4 2020 | |
| $6.98M | 0.29% | Not reported | Not reported | Q3 2013 | |
| $6.85M | 0.28% | 0.00% | +3.0% | Q3 2019 | |
| $6.8M | 0.28% | 0.04% | -6.5% | Q4 2021 | |
| $6.53M | 0.27% | 0.00% | +298.3% | Q3 2019 | |
| $6.2M | 0.25% | 0.00% | -47.9% | Q3 2013 | |
| $5.97M | 0.25% | Not reported | +62.7% | Q1 2019 | |
| $5.57M | 0.23% | Not reported | +558.5% | Q1 2026 | |
| $5M | 0.21% | 0.00% | Not reported | Q2 2013 | |
| $4.9M | 0.20% | Not reported | -21.9% | Q4 2013 | |
| $4.63M | 0.19% | 0.00% | Not reported | Q3 2019 | |
| $4.61M | 0.19% | 0.00% | -60.1% | Q2 2013 | |
| $4.59M | 0.19% | 0.00% | +260.6% | Q2 2025 | |
| $4.37M | 0.18% | 1.01% | +279.5% | Q3 2021 | |
| $4.31M | 0.18% | 0.17% | +1630.3% | Q3 2017 | |
| $4.21M | 0.17% | Not reported | +835.6% | Q2 2013 | |
| $4.19M | 0.17% | 0.04% | +48.7% | Q1 2021 | |
| $3.86M | 0.16% | Not reported | +31.1% | Q2 2020 | |
| $3.75M | 0.15% | 0.00% | +96.0% | Q1 2017 | |
| $3.59M | 0.15% | 0.00% | Not reported | Q1 2017 | |
| $3.58M | 0.15% | 0.00% | +15.3% | Q3 2013 | |
| $3.53M | 0.15% | Not reported | +13.7% | Q1 2026 | |
| $3.17M | 0.13% | 0.24% | Not reported | Q1 2020 | |
| $3.12M | 0.13% | 0.00% | Not reported | Q4 2025 | |
| $3.08M | 0.13% | Not reported | -66.8% | Q2 2024 | |
| $3.01M | 0.12% | Not reported | -60.1% | Q2 2023 | |
| $2.98M | 0.12% | 0.00% | Not reported | Q1 2017 | |
| $2.86M | 0.12% | 0.00% | Not reported | Q1 2022 | |
| $2.79M | 0.11% | Not reported | -47.3% | Q3 2018 | |
| $2.72M | 0.11% | 0.37% | +121.5% | Q4 2014 | |
| $2.57M | 0.11% | 0.05% | New | Q2 2026 | |
| $2.57M | 0.11% | Not reported | +109.4% | Q1 2019 | |
| $2.55M | 0.10% | Not reported | Not reported | Q1 2020 | |
| $2.48M | 0.10% | 0.00% | Not reported | Q3 2019 | |
| $2.4M | 0.10% | Not reported | New | Q2 2026 | |
| $2.35M | 0.10% | 0.00% | +79.3% | Q1 2017 | |
| $2.31M | 0.09% | Not reported | -33.9% | Q3 2016 | |
| SPPROCSofgen Pharma, S.A. | $2.29M | 0.09% | 0.04% | Not reported | Q4 2025 |
| $2.29M | 0.09% | Not reported | -86.9% | Q1 2021 | |
| $2.25M | 0.09% | Not reported | -48.6% | Q2 2013 | |
| Q1 2026Reported May 15, 2026283 positions | |||||
| $104M | 3.29% | Not reported | -26.8% | Q1 2014 | |
| $38.1M | 1.20% | Not reported | -47.5% | Q2 2025 | |
| $18.5M | 0.58% | 0.00% | +1177.8% | Q3 2019 | |
| $12.5M | 0.39% | Not reported | Not reported | Q1 2021 | |
| $11.5M | 0.36% | 0.00% | Not reported | Q2 2013 | |
| $10.7M | 0.34% | 0.00% | Not reported | Q3 2018 | |
| $10.4M | 0.33% | Not reported | Not reported | Q1 2021 | |
| $9.94M | 0.31% | 0.53% | Not reported | Q2 2013 | |
| $9.46M | 0.30% | 1.87% | Not reported | Q4 2020 | |
| $7.9M | 0.25% | 0.00% | +1.4% | Q3 2013 | |
| $6.4M | 0.20% | Not reported | Not reported | Q3 2016 | |
| $6.28M | 0.20% | 0.00% | Not reported | Q4 2016 | |
| $6.28M | 0.20% | 0.02% | +692.8% | Q2 2013 | |
| $5.59M | 0.18% | Not reported | +1.1% | Q2 2024 | |
| $5.54M | 0.18% | 0.00% | -76.7% | Q3 2018 | |
| $5.5M | 0.17% | Not reported | Not reported | Q4 2013 | |
| $5.45M | 0.17% | 0.00% | Not reported | Q3 2019 | |
| $5.32M | 0.17% | Not reported | Not reported | Q3 2018 | |
| $4.9M | 0.15% | Not reported | Not reported | Q2 2023 | |
| $3.64M | 0.12% | 0.02% | +199.4% | Q1 2021 | |
| $3.45M | 0.11% | 0.67% | Not reported | Q2 2023 | |
| $3.44M | 0.11% | Not reported | Not reported | Q1 2019 | |
| $3.41M | 0.11% | Not reported | +10.9% | Q3 2016 | |
| $3.39M | 0.11% | 0.12% | Not reported | Q4 2020 | |
| $3.34M | 0.11% | 0.12% | +94.5% | Q4 2021 | |
| $3.19M | 0.10% | Not reported | +315.2% | Q2 2013 | |
| $3.19M | 0.10% | Not reported | -14.5% | Q4 2020 | |
| $3.18M | 0.10% | 0.00% | Not reported | Q4 2024 | |
| $3.1M | 0.10% | Not reported | New | Q1 2026 | |
| $3.08M | 0.10% | 0.18% | +80.9% | Q2 2018 | |
| $3.06M | 0.10% | 0.10% | +280.0% | Q1 2021 | |
| $3.05M | 0.10% | Not reported | Not reported | Q2 2014 | |
| $3.04M | 0.10% | 0.05% | +2.2% | Q4 2021 | |
| $2.94M | 0.09% | 0.00% | -9.8% | Q3 2013 | |
| $2.9M | 0.09% | Not reported | +925.6% | Q3 2013 | |
| $2.79M | 0.09% | Not reported | Not reported | Q2 2013 | |
| $2.62M | 0.08% | Not reported | +85.7% | Q2 2020 | |
| $2.6M | 0.08% | 0.00% | +52.3% | Q4 2015 | |
| $2.56M | 0.08% | 0.01% | +40.8% | Q1 2022 | |
| $2.32M | 0.07% | Not reported | New | Q1 2026 | |
| $2.28M | 0.07% | 0.03% | -43.2% | Q2 2025 | |
| $2.24M | 0.07% | Not reported | -5.7% | Q3 2019 | |
| $2.15M | 0.07% | 0.00% | -1.3% | Q1 2017 | |
| $2.12M | 0.07% | Not reported | +50.7% | Q2 2013 | |
| $2.07M | 0.07% | Not reported | -42.8% | Q2 2013 | |
| $1.99M | 0.06% | 0.63% | +135.2% | Q1 2015 | |
| $1.97M | 0.06% | Not reported | New | Q1 2026 | |
| $1.92M | 0.06% | 0.00% | +480.4% | Q1 2017 | |
| $1.89M | 0.06% | Not reported | Not reported | Q4 2016 | |
| $1.88M | 0.06% | Not reported | -54.2% | Q2 2023 | |
| Q4 2025Reported Feb 13, 2026267 positions | |||||
| $132M | 4.31% | Not reported | Not reported | Q1 2014 | |
| $91.8M | 3.01% | Not reported | Not reported | Q2 2014 | |
| $76.2M | 2.50% | Not reported | +31.2% | Q2 2025 | |
| $31.4M | 1.03% | Not reported | Not reported | Q4 2022 | |
| $28.8M | 0.94% | 0.00% | Not reported | Q3 2018 | |
| $18.6M | 0.61% | 0.01% | Not reported | Q3 2013 | |
| $9.71M | 0.32% | 0.08% | Not reported | Q3 2024 | |
| $7.32M | 0.24% | 0.01% | Not reported | Q2 2013 | |
| $6.42M | 0.21% | 0.00% | Not reported | Q3 2018 | |
| $6.31M | 0.21% | 0.00% | -23.5% | Q3 2013 | |
| $5.93M | 0.19% | Not reported | Not reported | Q3 2020 | |
| $5.86M | 0.19% | 0.00% | Not reported | Q2 2025 | |
| $5.73M | 0.19% | 0.05% | +61.2% | Q4 2021 | |
| $5.66M | 0.19% | 0.00% | Not reported | Q3 2013 | |
| $5.56M | 0.18% | 0.00% | Not reported | Q2 2013 | |
| $5.36M | 0.18% | Not reported | +13.5% | Q2 2024 | |
| $5.09M | 0.17% | 0.08% | +598.6% | Q3 2024 | |
| $4.23M | 0.14% | Not reported | +540.4% | Q2 2023 | |
| $4.08M | 0.13% | Not reported | +545.2% | Q1 2023 | |
| $3.94M | 0.13% | 0.05% | Not reported | Q2 2025 | |
| $3.84M | 0.13% | 0.00% | Not reported | Q2 2013 | |
| $3.65M | 0.12% | Not reported | Not reported | Q4 2020 | |
| SPPROCSofgen Pharma, S.A. | $3.39M | 0.11% | 0.04% | New | Q4 2025 |
| $3.19M | 0.10% | Not reported | Not reported | Q2 2013 | |
| $3.16M | 0.10% | 0.00% | Not reported | Q3 2013 | |
| $3.05M | 0.10% | 0.00% | Not reported | Q1 2017 | |
| $3.01M | 0.10% | Not reported | +614.7% | Q3 2016 | |
| $2.9M | 0.10% | 0.19% | +167.4% | Q1 2020 | |
| $2.74M | 0.09% | Not reported | Not reported | Q3 2019 | |
| $2.73M | 0.09% | 0.12% | Not reported | Q3 2024 | |
| $2.68M | 0.09% | 0.26% | New | Q4 2025 | |
| $2.64M | 0.09% | Not reported | +323.9% | Q1 2024 | |
| $2.55M | 0.08% | 0.64% | +276.4% | Q3 2021 | |
| $2.54M | 0.08% | Not reported | Not reported | Q3 2013 | |
| $2.43M | 0.08% | 0.00% | Not reported | Q3 2016 | |
| $2.39M | 0.08% | Not reported | +457.3% | Q3 2019 | |
| $2.35M | 0.08% | 0.00% | Not reported | Q1 2022 | |
| $2.32M | 0.08% | 0.07% | +26.2% | Q3 2023 | |
| $2.29M | 0.08% | 0.00% | Not reported | Q1 2017 | |
| $2.27M | 0.07% | Not reported | +1729.7% | Q4 2024 | |
| $2.2M | 0.07% | Not reported | +249.2% | Q3 2024 | |
| $2.17M | 0.07% | Not reported | +484.4% | Q3 2025 | |
| $2.12M | 0.07% | Not reported | -5.2% | Q2 2013 | |
| $2.08M | 0.07% | 0.01% | Not reported | Q1 2024 | |
| $2M | 0.07% | 0.01% | Not reported | Q1 2024 | |
| $1.99M | 0.07% | 0.00% | -19.9% | Q4 2015 | |
| $1.98M | 0.06% | Not reported | +191.9% | Q4 2013 | |
| $1.96M | 0.06% | 0.00% | Not reported | Q2 2023 | |
| $1.86M | 0.06% | Not reported | +130.4% | Q4 2022 | |
| $1.86M | 0.06% | Not reported | +276.8% | Q2 2013 | |
| Q3 2025Reported Nov 14, 2025249 positions | |||||
| $87.6M | 3.55% | Not reported | -3.3% | Q1 2021 | |
| $73.1M | 2.97% | Not reported | +147.9% | Q2 2018 | |
| $58.1M | 2.36% | Not reported | +541.7% | Q2 2025 | |
| $14.3M | 0.58% | 2.67% | Not reported | Q4 2020 | |
| $12.9M | 0.52% | Not reported | +22.2% | Q2 2020 | |
| $11.9M | 0.48% | Not reported | +19.9% | Q2 2016 | |
| $9.95M | 0.40% | Not reported | Not reported | Q4 2023 | |
| $9.52M | 0.39% | 0.03% | +709.5% | Q2 2025 | |
| $8.16M | 0.33% | Not reported | Not reported | Q2 2023 | |
| $7.46M | 0.30% | 0.00% | +2911.3% | Q3 2013 | |
| $7.43M | 0.30% | Not reported | Not reported | Q2 2013 | |
| $5.83M | 0.24% | Not reported | +290.7% | Q2 2024 | |
| $5.3M | 0.21% | 0.03% | +34.2% | Q4 2021 | |
| $5M | 0.20% | 0.00% | Not reported | Q1 2017 | |
| $4.67M | 0.19% | 1.05% | Not reported | Q2 2013 | |
| $3.79M | 0.15% | 0.00% | Not reported | Q4 2016 | |
| $3.62M | 0.15% | 0.02% | Not reported | Q3 2013 | |
| $3.47M | 0.14% | 0.00% | -75.0% | Q3 2018 | |
| $3.45M | 0.14% | 0.03% | +189.1% | Q2 2025 | |
| $3.06M | 0.12% | 0.37% | Not reported | Q2 2013 | |
| $3.06M | 0.12% | Not reported | +23.2% | Q1 2021 | |
| $3.03M | 0.12% | 0.00% | -7.6% | Q4 2015 | |
| $3.02M | 0.12% | 0.00% | Not reported | Q2 2013 | |
| $2.86M | 0.12% | Not reported | -22.9% | Q1 2021 | |
| $2.77M | 0.11% | Not reported | Not reported | Q3 2019 | |
| $2.74M | 0.11% | Not reported | Not reported | Q4 2016 | |
| $2.72M | 0.11% | 0.00% | +406.1% | Q3 2019 | |
| $2.47M | 0.10% | 0.01% | +34.3% | Q2 2021 | |
| $2.46M | 0.10% | 0.01% | Not reported | Q1 2019 | |
| $2.39M | 0.10% | 0.00% | +404.4% | Q1 2017 | |
| $2.35M | 0.10% | Not reported | +40.9% | Q2 2021 | |
| $2.28M | 0.09% | Not reported | +535.9% | Q4 2014 | |
| $2.26M | 0.09% | Not reported | -91.6% | Q3 2013 | |
| $2.22M | 0.09% | 0.03% | Not reported | Q1 2021 | |
| $2.05M | 0.08% | Not reported | -29.9% | Q2 2013 | |
| $2M | 0.08% | 0.00% | Not reported | Q2 2013 | |
| $1.97M | 0.08% | 0.01% | New | Q3 2025 | |
| $1.82M | 0.07% | 0.25% | New | Q3 2025 | |
| $1.79M | 0.07% | 0.53% | New | Q3 2025 | |
| $1.74M | 0.07% | 0.05% | Not reported | Q3 2023 | |
| $1.73M | 0.07% | Not reported | Not reported | Q1 2015 | |
| $1.72M | 0.07% | 0.00% | Not reported | Q1 2015 | |
| $1.72M | 0.07% | 0.13% | +665.8% | Q2 2024 | |
| $1.72M | 0.07% | Not reported | -15.0% | Q4 2021 | |
| $1.68M | 0.07% | 0.01% | -59.7% | Q3 2013 | |
| $1.64M | 0.07% | 0.00% | +41.7% | Q4 2024 | |
| PPCYNProcyon Corp | $1.62M | 0.07% | 0.93% | -62.9% | Q2 2018 |
| $1.55M | 0.06% | 0.34% | Not reported | Q4 2020 | |
| $1.55M | 0.06% | 0.21% | +498.2% | Q4 2014 | |
| $1.41M | 0.06% | 0.64% | Not reported | Q2 2018 | |
Premium opens every quarter this fund has filed